SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Forslund Maria 1978)
 

Sökning: WFRF:(Forslund Maria 1978) > Combined oral contr...

Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review

Forslund, Maria, 1978 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology
Melin, J. (författare)
Alesi, S. (författare)
visa fler...
Piltonen, T. (författare)
Romualdi, D. (författare)
Tay, C. T. (författare)
Witchel, S. (författare)
Pena, A. (författare)
Mousa, A. (författare)
Teede, H. (författare)
visa färre...
 (creator_code:org_t)
2023-03-27
2023
Engelska.
Ingår i: Clinical Endocrinology. - : Wiley. - 0300-0664 .- 1365-2265. ; 99:1, s. 79-91
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • ObjectiveAs part of the update of the International Evidence-Based Guidelines for the Assessment and Management of polycystic ovary syndrome (PCOS), a systematic review was performed to inform evidence-based recommendations. DesignSystematic review. Only randomised controlled trial were included. PatientsWomen with PCOS; the use of combined oral contraceptive pills (COCP) was compared with no medical treatment. MeasurementsOutcomes were designed in collaboration with clinical experts, researchers, and consumers. Critical outcomes included hirsutism, irregular cycles, quality of life, body mass index (BMI), and weight. Results1660 publications were identified, but only four studies were included. No studies could be combined for meta-analysis. COCP treatment improved cycle regularity compared with no medical treatment (100% vs. 0%, with low certainty of evidence). COCP showed no difference in improvement of hirsutism or BMI compared with placebo or lifestyle; a lower weight after COCP compared with no treatment (mean difference [MD] -8.0 (95% confidence interval, CI -11.67); -4.33 kg); and improvement in quality of life (MD 1.2 [95% CI 0.96]; 1.44), but these results were all very low certainty of evidence. ConclusionResults show that COCP benefit cycle regulation, but other benefits or potential adverse effects were only identified with very low certainty of evidence. The COCP is frontline medical treatment in PCOS, but this is still based on established efficacy in the broader general population. Our results show that research in PCOS is seriously lacking and should be prioritised to capture core reproductive, metabolic and psychological outcomes important in PCOS.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)

Nyckelord

combined oral contraceptive pills
hyperandrogenism
irregular cycles
polycystic ovary syndrome
treatment
randomized controlled-trial
androgen excess
women
metformin
risk
endometrial
prevalence
anxiety
cancer
sample
Endocrinology & Metabolism

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy